Rankings
▼
Calendar
TARS FY 2018 Earnings — Tarsus Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
TARS
Tarsus Pharmaceuticals, Inc.
$3B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1,000
Operating Income
-$1M
Net Income
-$1M
EPS (Diluted)
$-0.31
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$9,000
Balance Sheet
Total Assets
$2M
Total Liabilities
$4M
Stockholders' Equity
-$1M
Cash & Equivalents
$2M
← Q1 2018
All Quarters
